Literature DB >> 24761897

Computer tomography and magnetic resonance image manifestations of primary hepatic neuroendocrine cell carcinomas.

Juan Huang1, Jian-Qun Yu, Jia-Yu Sun.   

Abstract

AIM: This study aims to investigate the manifestation of CT, MRI and dynamic enhanced scans for primary hepatic neuroendocrine cell carcinoma.
METHODS: CT or MRI arterial and venous phase scan images of 19 cases of pathologically confirmed PHNEC were retrospectively analyzed.
RESULTS: 14 cases (73.68%) with single lesion, 5 cases (26.3%) with multiple lesions, with an average diameter of 13.2 cm. Some 12 cases (63.16%) showed inhomogeneous enhancement, seven cases (36.8%) showed homogeneous enhancement, 13 cases (68.4%) demonstrated significant enhancement in the arterial phase, 13 cases (68.4%) had significantly enhanced portal venous phase including 7 cases (36.8 %) with portal venous phase density or signal above the arterial phase and 5 cases (26.3%) with the portal vein density or signal below the arterial phase. Seven cases (36.8%) had continued strengthened separate shadows in the center of the lesion. Thrombosis were not seen in portal veins.
CONCLUSION: CT and MRI images of liver cell neuroendocrine carcinoma have certain characteristics that can provide valuable information for diagnosis and differential diagnosis.

Entities:  

Mesh:

Year:  2014        PMID: 24761897     DOI: 10.7314/apjcp.2014.15.6.2759

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  3 in total

1.  MR imaging of primary hepatic neuroendocrine neoplasm and metastatic hepatic neuroendocrine neoplasm: a comparative study.

Authors:  RuoFan Sheng; YanHong Xie; MengSu Zeng; Yuan Ji; ShengXiang Rao; CaiZhong Chen
Journal:  Radiol Med       Date:  2015-04-24       Impact factor: 3.469

2.  Comparative Clinical Analysis of Gastroenteropancreatic Neuroendocrine Carcinomas with Liver Metastasis and Primary Hepatic Neuroendocrine Carcinomas.

Authors:  Meng-Jun Qiu; Yao-Bing Chen; Ning-Rui Bi; Sheng-Li Yang; Xiao-Xiao He; Zhi-Fan Xiong
Journal:  Dis Markers       Date:  2018-10-17       Impact factor: 3.434

3.  Combination therapies for primary hepatic neuroendocrine carcinoma: a case report.

Authors:  Richi Nakatake; Morihiko Ishizaki; Kosuke Matui; Hiroaki Yanagimoto; Kentaro Inoue; Masaki Kaibori; Yusai Kawaguchi; Masanori Kon
Journal:  Surg Case Rep       Date:  2017-09-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.